100,000 Surveillance of the Safety, Efficacy, and Bacterial Resistance Surveillance of Substituted Lapine for Injection in the Real World

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPN-17010364

Enrollment

Unknown

Registered

2017-01-09

Start date

2017-01-06

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious disease

Interventions

Case series:Teicoplanin for injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Prescription for teicoplanin in patients.

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

Measure	Time frame
Clinical efficacy;	—

Secondary

Measure	Time frame
Bacterial clearance rate;Comprehensive effect;	—

Countries

China

Contacts

Public ContactYingchun Xu

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

xycpumch@139.com+86 13911303028

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026